-
-
-
-
-
-
-
Oppenheimer on Pharvaris B.V. (PHVS): runway sufficient to support ops through key milestones
-
-
-
-
-
-
-
Pharvaris expects pivotal HAE study data in third quarter 2026
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Pharvaris B.V. (PHVS)
-
-
-
-
-
-
-
Pharvaris (PHVS) Presents Data Highlighting the Potential for Deucrictibant
-
-
-
-
-
-
-
JMP Securities Reiterates Market Outperform Rating on Pharvaris B.V. (PHVS)
-
-
-
-
-
-
-
Pharvaris B.V. (PHVS) PT Raised to $42 at Oppenheimer
-
-
-
416,806 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

